Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New mitotic kinesin KSP inhibitors jointly reported by Cytokinetics and GSK

Feb. 25, 2004

New macrolide-containing conjugates and their use reported by Pliva

Feb. 25, 2004

Inflammation and elevated C-reactive protein increase the risk of colon cancer

Feb. 25, 2004

New antitumor fredericamycin derivatives discovered at Biofrontera

Feb. 24, 2004

Novartis presents novel tyrosine kinase inhibitors with utility in leukemia

Feb. 24, 2004

New protein kinase inhibitors for cancer therapy designed at Novartis

Feb. 24, 2004

Phase I trial of PT-523 commences enrollment

Feb. 24, 2004

New tubulysin conjugates for cancer therapy claimed by Morphochem

Feb. 24, 2004

Novartis presents new modulators of Smac/IAP interaction

Feb. 24, 2004

Exelixis files IND for XL-647

Feb. 23, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...